Physician profile
John Hong
NPI 1932127008
$6,036.09
in general payments reported to CMS, 2019-2025
33 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,752 · 2020: $354 · 2021: $1,128 · 2022: $492 · 2023: $735 · 2024: $1,066 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,309.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,839.21 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $873.38 | 2019-2024 | Senza |
| Boston Scientific Corporation | $580.28 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Advantage System |
| Spinal Simplicity, LLC | $328.84 | 2022-2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $314.98 | 2019-2021 | |
| Biotronik Nro, INC. | $280.45 | 2024-2025 | Prospera |
| Stimwave Technologies Incorporated | $263.57 | 2022 | |
| Medtronic USA, INC. | $235.87 | 2019 | |
| Medtronic, INC. | $188.03 | 2023-2025 | Intellis Adaptivestim, Corevalve Evolut R, Inceptiv |
| Collegium Pharmaceutical, INC. | $177.53 | 2019-2024 | Xtampza |
| Mml US, INC. | $152.84 | 2024 | Reactiv8 |
| Saluda Medical Americas, INC. | $117.12 | 2023-2024 | Evoke Scs, Evoke |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $64.76 | 2025 | Senza |
| Pfizer INC. | $59.86 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $49.52 | 2022-2023 | Trivisc Sodium Hyaluronate |
| Painteq LLC | $48.79 | 2023-2024 | Painteq |
| Depuy Synthes Sales INC. | $41.60 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $32.37 | 2019 | |
| Biodelivery Sciences International, INC. | $28.88 | 2019-2021 | |
| Zyla Life Sciences, INC. | $28.76 | 2020 | |
| Allergan, INC. | $26.41 | 2019-2021 | |
| Orthofix Medical, INC. | $24.57 | 2019 | |
| Fidia Pharma USA INC. | $24.10 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.00 | 2019 | |
| Active Medical, LLC | $23.95 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.91 | 2019 | |
| Ibsa Pharma INC. | $19.17 | 2023 | Tirosint, Licart |
| Astrazeneca Pharmaceuticals LP | $16.87 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.75 | 2019 | |
| Vertiflex, INC. | $14.20 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.74 | 2020 | |
| Foundation Fusion Solutions, LLC | $7.83 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.